What does treatment access mean to you?

What does treatment access mean to you?

When someone facing cancer gains access to treatment, they gain access to life. With oral chemotherapies, access to treatment isn’t simply a one-time occurrence. Each and every day, tens of thousands of cancer patients take life-saving medication they receive free-of-cost – all thanks to the unseen work of partners, donors, and Max team members.

Treatment access means so much to us at The Max Foundation because we understand what it means to patients. We know so many people living beyond their cancer diagnoses because of the access we are able to provide. We know the privilege of watching patients grow, get married, start careers, and give back to their communities. While treatment access means the world to us and our patients, there are many who do not realize the freedom, joy, and dignity that comes with access to a daily dose.

Words to live by

The Max Malaysia team recently attended the Malaysian Society of Haematology (MSH) Annual Scientific Meeting. Surrounded by healthcare professionals, patient advocates, pharmaceutical organizations, and more, we thought it was a great opportunity to hear what people gain when they have access to treatment.

So we created a fun way for people to share their thoughts – hundreds of buttons with different answers to the question, “What does treatment access mean to you?” Attendees selected (and sometimes wrote out) words that reflected their thoughts and then pinned them to our display. Watch as delegates at the meeting shared their responses.

[vc_video link=’https://www.youtube.com/playlist?list=PLIMc_PiZdPhTt78Hj6ZwhXk07BIqrNUvi’]

What about you? What does treatment access mean to you and your community? Share your words in the comments below!

This experience with our new friends at the MSH Annual Scientific Meeting showed that everyone has a role in treatment access. We were proud to represent Max at MSH and to showcase the ways treatment access empowers patients around the world.

Mei Ching Ong is the Region Head of Asia Pacific, Eastern Europe and Central Asia. Mei Ching is based in our regional office located in Kuala Lumpur, Malaysia. Although growing up in a town facing the South China Sea with beautiful beaches, she is enjoying mountains, jungles and greens more than water, that explains she is spending most of her early morning during weekends in greens. Believing in everyone is connected with each another in this cycle we call life, Mei Ching also believes everyone has roles to play to strengthen the overall well-being of lives of human.

Related Articles

  • On World Cancer Day 2020, we are reflecting on what progress means to us

    On World Cancer Day 2020, we are reflecting on what progress means to us

    For the 20th anniversary of World Cancer Day, we asked our global team members, physicians, patients, caregivers, and advocates to share what progress in cancer care means to them. Progress means all cancer patients get the treatment they deserve.[/e World Cancer Day, celebrated on February 4, is a global initiative that aims to raise awareness….

  • I am a Spartan – Thilip’s Story

    I am a Spartan – Thilip’s Story

    Being a patient or I better call myself and others as a Spartan, someone who is fighting for something each and every day.” –Thilip Kumar Ragavan

    We first met Thilip Kumar Ragavan in May 2014. He was a young chronic myeloid leukemia Spartan in the patient workshop at Hospital Ampang and was newly diagnosed with CML at that time, but the smile never left his face. Bright, vibrant, energetic, and positive – that’s Thilip.

  • 7 Questions for Dr. Jayasree Iyer of Access to Medicine Foundation

    7 Questions for Dr. Jayasree Iyer of Access to Medicine Foundation

    Dr. Jayasree Iyer, Executive Director of the Access to Medicine Foundation (ATMF), sits down with The Max Foundation and answers seven questions about the Access to Medicine Index, emerging trends in treatment access, and the role of collaborative access initiatives in treating chronic diseases.